Phase I funding — which allows up to $ 250,000 for an academic idea, such as
decoding the genetic sequence of a protein or studying targeted drug delivery by
using magnetic nanoparticles — is available from federal funding and foundations.
Study to conclude in late August; data will be
used in the design of an information - rich
Phase III study for the prevention of heart attack Reykjavik, ICELAND, June 18, 2004 —
deCODE genetics (Nasdaq: DCGN) today announced the completion of enrollment for its ten - week,...